Company Filing History:
5 out of 8 
1 out of 52 
Years Active: 1997-2002
Title: Jeremy Carver: Innovator in Glycosyltransferase Inhibitors
Introduction
Jeremy Carver is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biochemistry, particularly in the design of inhibitors for glycosyltransferases. With a total of 5 patents to his name, Carver's work has the potential to impact therapeutic treatments significantly.
Latest Patents
One of Carver's latest patents focuses on designing inhibitors for glycosyltransferases. This invention relates to computer-implemented methods for designing these inhibitors, as well as compositions and treatments that utilize them. Another notable patent involves novel 3, 5, and/or 6 substituted analogues of swainsonine. This invention details processes for their preparation and their application as therapeutic agents, including pharmaceutical compositions containing these compounds.
Career Highlights
Throughout his career, Jeremy Carver has worked with reputable organizations such as Glycodesign, Inc. and Mount Sinai Hospital Corporation. His experience in these institutions has allowed him to refine his expertise in biochemistry and patent development.
Collaborations
Carver has collaborated with several professionals in his field, including Rajan N Shah and Igor Tvaroska. These collaborations have likely contributed to the innovative nature of his work and the successful development of his patents.
Conclusion
Jeremy Carver is a distinguished inventor whose work in glycosyltransferase inhibitors showcases his innovative spirit and dedication to advancing therapeutic solutions. His contributions to the field are noteworthy and continue to influence the landscape of biochemistry.